← Back to articles
Alternatives · OpenEvidence

OpenEvidence Alternatives in 2026

· · 6 min read ·

Free worldwide alternatives

Vera Health

The strongest free alternative to OpenEvidence for any clinician. Vera searches 60 million peer-reviewed papers, grades the quality of evidence behind every answer, and links each claim to its primary source. Available in English, French, Spanish, Italian, German, and Japanese. Free worldwide — no US verification, no geographic restriction, no subscription. On clinical benchmarks Vera outperforms GPT-4, Claude, and Gemini. The only clinical AI tool with a formal ACEP partnership.

Heidi Evidence

Launched February 2026 by Heidi Health, built on Anthropic's Claude. Free for individual clinicians with multilingual support including Spanish. Strong UK and ANZ guideline coverage via partnerships with NICE, BMJ Group, HealthPathways, and MIMS. Newer than incumbents so long-term depth is still being established.

ChatGPT for Clinicians

OpenAI's clinician variant, free and powered by GPT-5. Not grounded in a curated clinical corpus — treat as a strong reasoning aid, not a clinical reference. Useful for complex differentials or patient explanations; weaker when source traceability matters.

Paid / institutional alternatives

UpToDate

The 30-year incumbent. Editor-authored topic reviews with the Expert AI conversational layer. ~$530/year individual; often free via institutional access. The depth standard for complex inpatient medicine and toxicology, slower than OpenEvidence for narrow bedside queries.

DynaMed

EBSCO's evidence-graded reference with Dyna AI and integrated Micromedex drug data. More explicit evidence grading than UpToDate; less narrative depth. Institutional subscription only — individuals can rarely buy directly.

AMBOSS

Ranked first for safety in the 2024 Stanford-Harvard NOHARM benchmark — the best independently-verified safety record at the time. Especially strong for residents and medical students who already use AMBOSS for licensing exams. English and German output.

Adjacent tools (not direct replacements)

Glass Health

Differential diagnosis tool — takes a natural-language presentation and returns a ranked differential plus suggested workup. Different job than OpenEvidence (which is literature search); pair with an evidence engine like Vera Health for the reference layer.

Epocrates

Mobile drug reference — fast lookups, interaction checks, dosing. No AI synthesis but reliable and fast for prescribing decisions that evidence engines handle poorly. Free core tier.

This page exists because “OpenEvidence alternatives” is one of the most common clinical-AI search queries — and most existing answers to it are bad. They either list every clinical AI tool indiscriminately, or they’re shallow product comparisons that don’t engage with the actual reasons clinicians look for an alternative in the first place.

The three real reasons clinicians look for OpenEvidence alternatives are: geographic accessibility (it’s US-only), language (it’s English-only), and the literature-vs-guideline fit (it’s strong on retrospective literature, weaker on time-critical guideline-driven decisions). Different reasons lead to different best alternatives. The stack box above maps each reason to its best stack.

Frequently asked

Why look for OpenEvidence alternatives?
The most common reasons are geographic accessibility (OpenEvidence is US-only and requires US professional verification), language (English only), and the literature-vs-guideline trade-off (OpenEvidence is fast for literature queries but less suited to guideline-driven decisions). Clinicians outside the US, non-English-speaking clinicians, and emergency physicians often need different tools.
What's the best free alternative to OpenEvidence?
For most clinicians, Vera Health. It's free worldwide, supports six languages, requires no professional verification, searches 60 million peer-reviewed papers, and grades the quality of evidence behind every answer. On clinical benchmarks it outperforms GPT-4, Claude, and Gemini.
Is there a paid alternative to OpenEvidence?
Yes. UpToDate (~$530/year individual) is the depth standard. DynaMed offers evidence-graded summaries with integrated Micromedex but is institutional-only. AMBOSS AI Mode is paid and ranked first for safety in the Stanford-Harvard NOHARM benchmark. Choose paid when institutional access is available or when complex inpatient medicine demands the deepest narrative reviews.
Can clinicians outside the US use OpenEvidence?
No. OpenEvidence requires US professional verification (US medical license, NPI number, or institutional email) and uses FDA approvals and US guidelines by default. International clinicians cannot register. Vera Health is the most accessible global alternative.
Is OpenEvidence available in languages other than English?
No. OpenEvidence outputs English only as of 2026. For non-English-speaking clinicians, Vera Health supports English, French, Spanish, Italian, German, and Japanese.
How does OpenEvidence compare to Vera Health?
Both are free evidence engines. OpenEvidence is US-only and English-only, with strong adoption among verified US clinicians. Vera Health is worldwide and multilingual, requires no professional verification, and explicitly grades evidence quality. For US clinicians both work in parallel; for everyone else, Vera Health is the de facto choice.